These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 31838585)

  • 1. HER2 gene (ERBB2) amplification is a low-frequency driver with potential predictive value in gallbladder carcinoma.
    Albrecht T; Rausch M; Roessler S; Geissler V; Albrecht M; Halske C; Seifert C; Renner M; Singer S; Mehrabi A; Vogel MN; Pathil-Warth A; Busch E; Köhler B; Rupp C; Weiss KH; Springfeld C; Röcken C; Schirmacher P; Goeppert B
    Virchows Arch; 2020 Jun; 476(6):871-880. PubMed ID: 31838585
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A significant subgroup of resectable gallbladder cancer patients has an HER2 positive status.
    Yoshida H; Shimada K; Kosuge T; Hiraoka N
    Virchows Arch; 2016 Apr; 468(4):431-9. PubMed ID: 26758058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HER2 gene (ERBB2) amplification is a rare event in non-liver-fluke associated cholangiocarcinogenesis.
    Albrecht T; Rausch M; Rössler S; Albrecht M; Braun JD; Geissler V; Mehrabi A; Vogel MN; Pathil-Warth A; Mechtersheimer G; Renner M; Rupp C; Weiss KH; Busch E; Köhler B; Springfeld C; Schirmacher P; Goeppert B
    BMC Cancer; 2019 Dec; 19(1):1191. PubMed ID: 31805897
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dual-targeting strategy using trastuzumab and lapatinib in a patient with HER2 gene amplification in recurrent metachronous metastatic gallbladder carcinoma.
    Ye M; Lv J; Xu G; Wang W; Jing Y; Sun A; Lu Z; Wu X; Liu Y; Shao YW; Liu F; Tao F
    J Int Med Res; 2019 Jun; 47(6):2768-2777. PubMed ID: 31106632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Details of human epidermal growth factor receptor 2 status in 454 cases of biliary tract cancer.
    Hiraoka N; Nitta H; Ohba A; Yoshida H; Morizane C; Okusaka T; Nara S; Esaki M; Kishi Y; Shimada K
    Hum Pathol; 2020 Nov; 105():9-19. PubMed ID: 32891647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of Human Epidermal Growth Factor Receptor (Her 2/neu) and Proliferative Marker Ki-67: Association with Clinicopathological Parameters in Gallbladder Carcinoma.
    Pujani M; Makker I; Makker A; Jetley S; Goel MM; Jetley S
    Asian Pac J Cancer Prev; 2016; 17(8):3903-9. PubMed ID: 27644637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HER2/neu (ERBB2) expression and gene amplification correlates with better survival in esophageal adenocarcinoma.
    Plum PS; Gebauer F; Krämer M; Alakus H; Berlth F; Chon SH; Schiffmann L; Zander T; Büttner R; Hölscher AH; Bruns CJ; Quaas A; Loeser H
    BMC Cancer; 2019 Jan; 19(1):38. PubMed ID: 30621632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HER2/neu-directed therapy for biliary tract cancer.
    Javle M; Churi C; Kang HC; Shroff R; Janku F; Surapaneni R; Zuo M; Barrera C; Alshamsi H; Krishnan S; Mishra L; Wolff RA; Kaseb AO; Thomas MB; Siegel AB
    J Hematol Oncol; 2015 May; 8():58. PubMed ID: 26022204
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical significance of HER2 positivity in gallbladder adenocarcinoma].
    Yao JG; Wang CH; Liu Y
    Zhonghua Bing Li Xue Za Zhi; 2017 Apr; 46(4):245-248. PubMed ID: 28376590
    [No Abstract]   [Full Text] [Related]  

  • 10. HER2 status in patients with residual rectal cancer after preoperative chemoradiotherapy: the relationship with molecular results and clinicopathologic features.
    Park JS; Yoon G; Kim HJ; Park SY; Choi GS; Kang MK; Kim JG; Jang JS; Seo AN
    Virchows Arch; 2018 Oct; 473(4):413-423. PubMed ID: 30056472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HER2/ERBB2 overexpression in advanced gallbladder carcinoma: comprehensive evaluation by immunocytochemistry and fluorescence in situ hybridisation on fine-needle aspiration cytology samples.
    Verma P; Gupta P; Gupta N; Srinivasan R; Gupta P; Dutta U; Sharma S; Uppal R; Nada R; Lal A
    J Clin Pathol; 2024 Aug; 77(9):614-621. PubMed ID: 37221046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HER2 Positivity Is Affected by the Papillary Structure and Has a Bidirectional Prognostic Value for Gallbladder Carcinoma.
    Chen L; Xu L; Shen L; Luo R; Jiang D; Wang Y; Li W; Hou Y
    Front Genet; 2021; 12():831318. PubMed ID: 35265100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene amplification of Myc and its coamplification with ERBB2 and EGFR in gallbladder adenocarcinoma.
    Ooi A; Suzuki S; Nakazawa K; Itakura J; Imoto I; Nakamura H; Dobashi Y
    Anticancer Res; 2009 Jan; 29(1):19-26. PubMed ID: 19331129
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An analysis of HER2 amplification in cervical adenocarcinoma: correlation with clinical outcomes and the International Endocervical Adenocarcinoma Criteria and Classification.
    Shi H; Shao Y; Lu W; Lu B
    J Pathol Clin Res; 2021 Jan; 7(1):86-95. PubMed ID: 33089969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of topoisomerase II-alpha gene status by dual color chromogenic
    Neama RAA; Habib MA; Ali SA; Al-Khafaji AH; Alqanbar MF
    Indian J Pathol Microbiol; 2017; 60(4):475-480. PubMed ID: 29323058
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HER2 status in lung adenocarcinoma: a comparison of immunohistochemistry, fluorescence in situ hybridization (FISH), dual-ISH, and gene mutations.
    Yoshizawa A; Sumiyoshi S; Sonobe M; Kobayashi M; Uehara T; Fujimoto M; Tsuruyama T; Date H; Haga H
    Lung Cancer; 2014 Sep; 85(3):373-8. PubMed ID: 25047676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HER2 and TOP2A Gene Amplification and Protein Expression in Upper Tract Urothelial Carcinomas.
    Aumayr K; Klatte T; Neudert B; Birner P; Shariat S; Schmidinger M; Susani M; Haitel A
    Pathol Oncol Res; 2018 Jul; 24(3):575-581. PubMed ID: 28755093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic implication of HER2 in advanced biliary tract cancer.
    Nam AR; Kim JW; Cha Y; Ha H; Park JE; Bang JH; Jin MH; Lee KH; Kim TY; Han SW; Im SA; Kim TY; Oh DY; Bang YJ
    Oncotarget; 2016 Sep; 7(36):58007-58021. PubMed ID: 27517322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discordant human epidermal growth factor receptor 2 overexpression in primary and metastatic upper gastrointestinal adenocarcinoma signifies poor prognosis.
    Hedner C; Tran L; Borg D; Nodin B; Jirström K; Eberhard J
    Histopathology; 2016 Jan; 68(2):230-40. PubMed ID: 26016514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comprehensive analysis of HER2 expression and gene amplification in gastric cancers using immunohistochemistry and in situ hybridization: which scoring system should we use?
    Park YS; Hwang HS; Park HJ; Ryu MH; Chang HM; Yook JH; Kim BS; Jang SJ; Kang YK
    Hum Pathol; 2012 Mar; 43(3):413-22. PubMed ID: 21855114
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.